BLRX 股價走勢圖
BLRX 收益
BioLineRx Ltd.
$3.1
-7.46%
$-0.25
收盤價：May 07, 16:00:00 GMT-4
$3.1
0%
$0
盤後：May 07, 20:00:00 GMT-4
返回
BioLineRx Ltd. (BLRX) 收益
關鍵數據
前收市價
$3.35
開盤價
$3.29
當日範圍
$3.1 - $3.33
52週區間
$2.15 - $7.77
交易量
13.5K
平均成交量
18.3K
股息收益率
--
每股盈餘 (TTM)
0.00
市值
$13.4M
什麼是 BioLineRx Ltd.？
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. The company is headquartered in Modiin, Central(Hamerkaz) and currently employs 24 full-time employees. The company went IPO on 2007-01-30. The firm is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The firm is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
